aged-care; assessment; hallucinations; older adults; training; treatment; Aged; Hallucinations/diagnosis; Hallucinations/therapy; Humans; Aging; Psychiatry and Mental Health
Abstract :
[en] Older adults experience hallucinations in a variety of social, physical, and mental health contexts. Not everyone is open about these experiences, as hallucinations are surrounded with stigma. Hence, hallucinatory experiences in older individuals are often under-recognized. They are also commonly misunderstood by service providers, suggesting that there is significant scope for improvement in the training and practice of professionals working with this age group. The aim of the present article is to increase knowledge about hallucinations in older adults and provide a practical resource for the health and aged-care workforce. Specifically, we provide a concise narrative review and critique of (1) workforce competency and training issues, (2) assessment tools, and (3) current treatments and management guidelines. We conclude with a brief summary including suggestions for service and training providers and future research.
Disciplines :
Neurosciences & behavior
Author, co-author :
Badcock, Johanna C; School of Psychological Science, University of Western Australia, Perth, Australia ; Perth Voices Clinic, Murdoch, Australia
Laroi, Frank ; Université de Liège - ULiège > Département de Psychologie ; Department of Biological and Medical Psychology, University of Bergen, Bergen, Norway ; Norwegian Centre of Excellence for Mental Disorders Research, University of Oslo, Oslo, Norway
Kamp, Karina; Department of Psychology and Behavioural Science, Aarhus University, Aarhus C, Denmark
Kelsall-Foreman, India; School of Psychological Science, University of Western Australia, Perth, Australia
Bucks, Romola S; School of Psychological Science, University of Western Australia, Perth, Australia
Weinborn, Michael; School of Psychological Science, University of Western Australia, Perth, Australia
Begemann, Marieke; Department of Biomedical Sciences of Cells and Systems, University Medical Center, Rijks Universiteit Groningen (RUG), Groningen, The Netherlands
Taylor, John-Paul; Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK
Collerton, Daniel; Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK
O'Brien, John T ; Department of Psychiatry, University of Cambridge, Cambridge, UK
El Haj, Mohamad; Laboratoire de Psychologie des Pays de la Loire (LPPL-EA 4638), Nantes Université, Univ Angers, Nantes, France
Ffytche, Dominic; Department of Old Age Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College, London, UK
Sommer, Iris E; Rijks Universiteit Groningen (RUG), Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, The Netherlands
United Nations. World Population Prospects: the 2019 revision. 2019. https://population.un.org/wpp/Publications/Files/ WPP2019-Highlights.pdf. Accessed October 11, 2019.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM 5. Washington, DC: American Psychiatric Pub Incorporated; 2013.
David AS. The cognitive neuropsychiatry of auditory verbal hallucinations: an overview. Cogn Neuropsychiatry. 2004;9(1-2):107-123.
Maijer K, Hayward M, Fernyhough C, et al. Hallucinations in children and adolescents: an updated review and practical recommendations for clinicians. Schizophr Bull. 2019;45(45 Suppl 1):S5-S23.
Collerton D, Taylor JP, Tsuda I, et al. How can we see things that are not there? Current insights into complex visual hallucinations. J Conscious Stud. 2016;23(7-8):195-227.
Blom JD. Defining and measuring hallucinations and their consequences - what is really the difference between a veridical perception and a hallucination? Categories of hallucinatory experience. In: Collerton D, Mosimann UP, Perry E, eds. The Neuroscience of Visual Hallucinations. Chichester: Wiley; 2014:23-45.
Waters F, Blom JD, Jardri R, Hugdahl K, Sommer IEC. Auditory hallucinations, not necessarily a hallmark of psychotic disorder. Psychol Med. 2018;48(4):529-536.
Larøi F, Bless JJ, Laloyaux J, et al. An epidemiological study on the prevalence of hallucinations in a general-population sample: effects of age and sensory modality. Psychiatry Res. 2019;272:707-714.
Maijer K, Begemann MJH, Palmen SJMC, Leucht S, Sommer IEC. Auditory hallucinations across the lifespan: a systematic review and meta-analysis. Psychol Med. 2018;48(6):879-888.
Kelsall-Foreman I, Bucks RS, Weinborn M, Gavett B, Badcock JC. An examination of the nature of hallucinations and other anomalous perceptual experiences in healthy communitydwelling older adults. Psychol Assess. (under revision).
O'Brien J, Taylor J, Ballard C, et al. Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management. J Neurol Neurosurg Psychiatry. 2020;91(5):512-519.
Linszen MMJ, van Zanten GA, Teunisse RJ, Brouwer RM, Scheltens P, Sommer IE. Auditory hallucinations in adults with hearing impairment: a large prevalence study. Psychol Med. 2019;49(1):132-139.
Cort E, Meehan J, Reeves S, Howard R. Very late-onset schizophrenia-like psychosis: a clinical update. J Psychosoc Nurs Ment Health Serv. 2018;56(1):37-47.
Dudley R, Aynsworth C, Mosimann U, et al. A comparison of visual hallucinations across disorders. Psychiatry Res. 2019;272:86-92.
Dauwan M, Linszen MMJ, Lemstra AW, Scheltens P, Stam CJ, Sommer IE. EEG-based neurophysiological indicators of hallucinations in Alzheimer's disease: comparison with dementia with Lewy bodies. Neurobiol Aging. 2018;67:75-83.
Badcock JC, Dehon H, Larøi F. Hallucinations in healthy older adults: an overview of the literature and perspectives for future research. Front Psychol. 2017;8:1134.
Kamp KS, O'Connor M, Spindler H, Moskowitz A. Bereavement hallucinations after the loss of a spouse: associations with psychopathological measures, personality and coping style. Death Stud. 2019;43(4):260-269.
Hugdahl K, Sommer IE. Auditory verbal hallucinations in schizophrenia from a levels of explanation perspective. Schizophr Bull. 2018;44(2):234-241.
Ffytche DH, Pinto R, Krzyzanowski H, et al. Visual hallucinations in dementia: preliminary findings from the Study of Hallucinations in Parkinson's disease, Eye disease and Dementia (SHAPED). Alzheimers Dement. 2017;13(7):P1461-P1462.
Goldberg SE, Whittamore KH, Harwood RH, Bradshaw LE, Gladman JR, Jones RG; Medical Crises in Older People Study Group. The prevalence of mental health problems among older adults admitted as an emergency to a general hospital. Age Ageing. 2012;41(1):80-86.
Wade DM, Brewin CR, Howell DC, White E, Mythen MG, Weinman JA. Intrusive memories of hallucinations and delusions in traumatized intensive care patients: an interview study. Br J Health Psychol. 2015;20(3):613-631.
Waters F, Dragovic M. Hallucinations as a presenting complaint in emergency departments: prevalence, diagnosis, and costs. Psychiatry Res. 2018;261:220-224.
Helvik AS, Selbæk G, Šaltyte Benth J, Røen I, Bergh S. The course of neuropsychiatric symptoms in nursing home residents from admission to 30-month follow-up. PLoS One. 2018;13(10):e0206147.
Marks E, Smith P, McKenna L. Living with tinnitus and the health care journey: an interpretative phenomenological analysis. Br J Health Psychol. 2019;24(2):250-264.
Drews T, Franck M, Radtke FM, et al. Postoperative delirium is an independent risk factor for posttraumatic stress disorder in the elderly patient: a prospective observational study. Eur J Anaesthesiol. 2015;32(3):147-151.
Renouf S, ffytche D, Pinto R, Murray J, Lawrence V. Visual hallucinations in dementia and Parkinson's disease: a qualitative exploration of patient and caregiver experiences. Int J Geriatr Psychiatry. 2018;33(10):1327-1334.
Castelnovo A, Cavallotti S, Gambini O, D'Agostino A. Post-bereavement hallucinatory experiences: a critical overview of population and clinical studies. J Affect Disord. 2015;186:266-274.
Rees WD. The hallucinations of widowhood. BMJ. 1971;4(5778):37-41.
Lee SA. The persistent complex bereavement inventory: a measure based on the DSM-5. Death Stud. 2015;39(7):399-410.
Larøi F, Luhrmann TM, Bell V, et al. Culture and hallucinations: overview and future directions. Schizophr Bull. 2014;40 (Suppl 4):S213-S220.
Badcock JC, Clark M, Morgan VA. Hallucinations in indigenous and non-indigenous Australians: findings from the second Australian national survey of psychosis. Schizophr Res. 2018;197:581-582.
Luhrmann TM, Padmavati R, Tharoor H, Osei A. Differences in voice-hearing experiences of people with psychosis in the U.S.A., India and Ghana: interview-based study. Br J Psychiatry. 2015;206(1):41-44.
Jarvis GE, Lyer S, Andermann L, Fung F. Culture and psychosis in clinical practice. In: Badcock JC, Paulik G eds. A Clinical Introduction to Psychosis: Foundations for Clinical Psychologists and Neuropsychologists. Cambridge, MA: Academic Press; 2019.
Parker R, Milroy H. Mental illness in Aboriginal and Torres Strait Islander peoples. In: Dudgeon P, Milroy H, Walker R, eds. Working Together: Aboriginal and Torres Strait Islander Mental Health and Wellbeing Principles and Practice. Canberra, Australia: Commonwealth of Australia, 2014:113-124.
Vilhauer RP. Stigma and need for care in individuals who hear voices. Int J Soc Psychiatry. 2017;63(1):5-13.
Pang L. Hallucinations experienced by visually impaired: Charles Bonnet syndrome. Optom Vis Sci. 2016;93(12):1466-1478.
Bennett G, Bennett KM. The presence of the dead: an empirical study. Mortality 2000;5(2):139-157.
Bennett S, Ilderton P, O'Brien JT, Taylor JP, Teodorczuk A. Teaching provision for old age psychiatry in medical schools in the UK and Ireland: a survey. BJPsych Bull. 2017;41(5):287-293.
Gordon KD, Felfeli T. Family physician awareness of Charles Bonnet syndrome. Fam Pract. 2018;35(5):595-598.
White MR, Stein-Parbury J, Orr F, Dawson A. Working with consumers who hear voices: the experience of early career nurses in mental health services in Australia. Int J Ment Health Nurs. 2019;28(2):605-615.
Corrigan PW, Druss BG, Perlick DA. The impact of mental illness stigma on seeking and participating in mental health care. Psychol Sci Public Interest. 2014;15(2):37-70.
McFerran D, Hoare DJ, Carr S, Ray J, Stockdale D. Tinnitus services in the United Kingdom: a survey of patient experiences. BMC Health Serv Res. 2018;18(1):110.
Orr F. I know how it feels: a voice-hearing simulation to enhance nursing students' empathy and self-efficacy [dissertation]. Sydney, Australia: Faculty of Health, University of Technology, Sydney; 2017.
Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010;19(4):539-549.
Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34-42.
Launay G, Slade P. The measurement of hallucinatory predisposition in male and female prisoners. Pers Individ Dif. 1981;2(3):221-234.
Larøi F, Van Der Linden M. Nonclinical participants' reports of hallucinatory experiences. Can J Behav Sci. 2005;37(1):33-43.
Siddi S, Ochoa S, Laroi F, et al. A cross-national investigation of hallucination-like experiences in 10 countries: the E-CLECTIC study. Schizophr Bull. 2019;45(45 Suppl 1):S43-S55.
Vellante M, Larøi F, Cella M, Raballo A, Petretto DR, Preti A. Hallucination-like experiences in the nonclinical population. J Nerv Ment Dis. 2012;200(4):310-315.
Stefanis NC, Hanssen M, Smirnis NK, et al. Evidence that three dimensions of psychosis have a distribution in the general population. Psychol Med. 2002;32(2):347-358.
Mark W, Toulopoulou T. Psychometric properties of "community assessment of psychic experiences": review and metaanalyses. Schizophr Bull. 2016;42(1):34-44.
Bell V, Halligan PW, Ellis HD. The Cardiff Anomalous Perceptions Scale (CAPS): a new validated measure of anomalous perceptual experience. Schizophr Bull. 2006;32(2):366-377.
Bell V, Halligan PW, Pugh K, Freeman D. Correlates of perceptual distortions in clinical and non-clinical populations using the Cardiff Anomalous Perceptions Scale (CAPS): associations with anxiety and depression and a re-validation using a representative population sample. Psychiatry Res. 2011;189(3):451-457.
Tamayo-Agudelo W, Jaén-Moreno MJ, León-Campos MO, Holguín-Lew J, Luque-Luque R, Bell V. Validation of the Spanish-language Cardiff Anomalous Perception Scale. PLoS One. 2019;14(3):e0213425.
Shine JM, Mills JMZ, Qiu J, et al. Validation of the psychosis and hallucinations questionnaire in non-demented patients with Parkinson's disease. Mov Disord Clin Pract. 2015;2(2):175-181.
Muller AJ, Mills JMZ, O'Callaghan C, et al. Informantand self-appraisals on the Psychosis and Hallucinations Questionnaire (PsycH-Q) enhances detection of visual hallucinations in Parkinson's disease. Mov Disord Clin Pract. 2018;5(6):607-613.
Capra C, Kavanagh DJ, Hides L, Scott JG. Current CAPE- 15: a measure of recent psychotic-like experiences and associated distress. Early Interv Psychiatry. 2017;11(5):411-417.
Mitchell CAA, Maybery MT, Russell-Smith SN, Collerton D, Gignac GE, Waters F. The structure and measurement of unusual sensory experiences in different modalities: the Multi-Modality Unusual Sensory Experiences Questionnaire (MUSEQ). Front Psychol. 2017;8(1363):1-17.
Haddock G, McCarron J, Tarrier N, Faragher EB. Scales to measure dimensions of hallucinations and delusions: the Psychotic Symptom Rating Scales (PSYRATS). Psychol Med. 1999;29(4):879-889.
Woodward TS, Jung K, Hwang H, et al. Symptom dimensions of the psychotic symptom rating scales in psychosis: a multisite study. Schizophr Bull. 2014;40 (Suppl 4):S265-S274.
Hoffman RE, Gueorguieva R, Hawkins KA, et al. Temporoparietal transcranial magnetic stimulation for auditory hallucinations: safety, efficacy and moderators in a fifty patient sample. Biol Psychiatry. 2005;58(2):97-104.
Hoffman RE, Hawkins KA, Gueorguieva R, et al. Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Arch Gen Psychiatry. 2003;60(1):49-56.
Mosimann UP, Collerton D, Dudley R, et al. A semistructured interview to assess visual hallucinations in older people. Int J Geriatr Psychiatry. 2008;23(7):712-718.
Aynsworth C, Collerton D, Dudley R. Measures of visual hallucinations: review and recommendations. Clin Psychol Rev. 2017;57:164-182.
Holiday KA, Pirogovsky-Turk E, Malcarne VL, et al. Psychometric properties and characteristics of the north-east visual hallucinations interview in Parkinson's disease. Mov Disord Clin Pract. 2017;4(5):717-723.
Sjölund S, Larsson M, Olofsson JK, Seubert J, Laukka EJ. Phantom smells: prevalence and correlates in a population-based sample of older adults. Chem Senses. 2017;42(4):309-318.
Bainbridge KE, Byrd-Clark D, Leopold D. Factors associated with phantom odor perception among US adults: findings from the national health and nutrition examination survey. JAMA Otolaryngol Head Neck Surg. 2018;144(9):807-814.
Rossell SL, Schutte MJL, Toh WL, et al. The questionnaire for psychotic experiences: an examination of the validity and reliability. Schizophr Bull. 2019;45(45 Suppl 1):S78-S87.
Wykes T, Hayward P, Thomas N, et al. What are the effects of group cognitive behaviour therapy for voices? A randomised control trial. Schizophr Res. 2005;77(2-3):201-210.
Drake R, Haddock G, Tarrier N, Bentall R, Lewis S. The Psychotic Symptom Rating Scales (PSYRATS): their usefulness and properties in first episode psychosis. Schizophr Res. 2007;89(1-3):119-122.
Moritz S, Kerstan A, Veckenstedt R, et al. Further evidence for the efficacy of a metacognitive group training in schizophrenia. Behav Res Ther. 2011;49(3):151-157.
Craig TK, Rus-Calafell M, Ward T, et al. AVATAR therapy for auditory verbal hallucinations in people with psychosis: a single-blind, randomised controlled trial. Lancet Psychiatry. 2018;5(1):31-40.
El Haj M, Jardri R, Larøi F, Antoine P. Hallucinations, loneliness, and social isolation in Alzheimer's disease. Cogn Neuropsychiatry. 2016;21(1):1-13.
El Haj M, Gallouj K, Dehon H, Roche J, Larøi F. Hallucinations in Alzheimer's disease: failure to suppress irrelevant memories. Cogn Neuropsychiatry. 2018;23(3):142-153.
El Haj M, Badcock JC, Jardri R, et al. A look into hallucinations: the relationship between visual imagery and hallucinations in Alzheimer's disease. Cogn Neuropsychiatry. 2019;24(4):275-283.
Larøi F, DeFruyt F, van Os J, Aleman A, Van der Linden M. Associations between hallucinations and personality structure in a non-clinical sample: comparison between young and elderly samples. Pers Individ Dif. 2005;39(1):189-200.
NICE. Parkinson's disease in adults. Report No.: NG71 2017. https://www.parkinsons.org.uk/professionals/resources/niceguideline- ng71-parkinsons-disease-adults. Accessed October 11, 2019.
ffytche DH. Visual hallucination and illusion disorders: a clinical guide. Adv Clin Neurosci Rehabil. 2004;4(2):16-18.
Sommer IE, Selten JP, Diederen KM, Blom JD. Dissecting auditory verbal hallucinations into two components: audibility (Gedankenlautwerden) and alienation (thought insertion). Psychopathology 2010;43(2):137-140.
Paulik G, Hayward M, Jones AM, Badcock JC. Evaluating the "C" and "B" in brief cognitive behaviour therapy for distressing voices in routine clinical practice in an uncontrolled study. Clin Psychol Psychother. 2019;26:734-742.
Hayes J, Leudar I. Experiences of continued presence: on the practical consequences of 'hallucinations' in bereavement. Psychol Psychother. 2016;89(2):194-210.
Hayes J, Steffen EM. Working with welcome and unwelcome presence in grief. In: Klass D, Steffen EM, eds. Continuing Bonds in Bereavement: New Directions for Research and Practice. New York, NY: Routledge; 2018.
van der Gaag M, van Oosterhout B, Daalman K, Sommer IE, Korrelboom K. Initial evaluation of the effects of Competitive Memory Training (COMET) on depression in schizophrenia-spectrum patients with persistent auditory verbal hallucinations: a randomized controlled trial. Br J Clin Psychol. 2012;51(2):158-171.
Badcock JC, Paulik G, eds. A Clinical Introduction to Psychosis: Foundations for Clinical Psychologists and Neuropsychologists. Cambridge, MA: Academic Press (an imprint of Elsevier); 2019.
Thomson C, Wilson R, Collerton D, Freeston M, Dudley R. Cognitive behavioural therapy for visual hallucinations: an investigation using a single-case experimental design. Cogn Behav Ther. 2017;10:e10.
Thompson DM, Hall DA, Walker DM, Hoare DJ. Psychological therapy for people with tinnitus: a scoping review of treatment components. Ear Hear. 2017;38(2):149-158.
Sommer IE, Kleijer H, Hugdahl K. Toward personalized treatment of hallucinations. Curr Opin Psychiatry. 2018;31(3):237-245.
Bloomfield K, MacDonald L, Finucane G, Snow B, Roxburgh R. Use of antipsychotic medications in patients with Parkinson's disease at Auckland City Hospital. Intern Med J. 2012;42(7):e151-e156.
Goetz CG, Fan W, Leurgans S. Antipsychotic medication treatment for mild hallucinations in Parkinson's disease: positive impact on long-term worsening. Mov Disord. 2008;23(11):1541-1545.
Chiesa D, Marengoni A, Nobili A, et al.; REPOSI Investigators. Antipsychotic prescription and mortality in hospitalized older persons. Psychogeriatrics 2017;17(6):397-405.
Madhusoodanan S, Shah P, Brenner R, Gupta S. Pharmacological treatment of the psychosis of Alzheimer's disease: what is the best approach? CNS Drugs. 2007;21(2):101-115.
Koponen M, Taipale H, Lavikainen P, et al. Risk of mortality associated with antipsychotic monotherapy and polypharmacy among community-dwelling persons with Alzheimer's disease. J Alzheimers Dis. 2017;56(1):107-118.
Li DD, Zhang YH, Zhang W, Zhao P. Meta-analysis of randomized controlled trials on the efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease. Front Neurosci. 2019;13:472.
Matsunaga S, Fujishiro H, Takechi H. Efficacy and safety of cholinesterase inhibitors for mild cognitive impairment: a systematic review and meta-analysis. J Alzheimers Dis. 2019;71(2):513-523.
Farlow MR, Somogyi M. Transdermal patches for the treatment of neurologic conditions in elderly patients: a review. Prim Care Companion CNS Disord. 2011;13(6): PCC.11r01149.
Sadowsky C, Perez JA, Bouchard RW, Goodman I, Tekin S. Switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch. CNS Neurosci Ther. 2010;16(1):51-60.
Reñé R, Ricart J, Hernández B; researchers in the Experience study. From high doses of oral rivastigmine to transdermal rivastigmine patches: user experience and satisfaction among caregivers of patients with mild to moderate Alzheimer disease. Neurologia. 2014;29(2):86-93.
Stryjer R, Ophir D, Bar F, Spivak B, Weizman A, Strous RD. Rivastigmine treatment for the prevention of electroconvulsive therapy-induced memory deficits in patients with schizophrenia. Clin Neuropharmacol. 2012;35(4):161-164.
Slotema CW, Aleman A, Daskalakis ZJ, Sommer IE. Metaanalysis of repetitive transcranial magnetic stimulation in the treatment of auditory verbal hallucinations: update and effects after one month. Schizophr Res. 2012;142(1-3):40-45.
Koops S, van den Brink H, Sommer IE. Transcranial direct current stimulation as a treatment for auditory hallucinations. Front Psychol. 2015;6:244.
Koops S, Sommer IEC. Transcranial direct current stimulation (tDCS) as a treatment for visual hallucinations: a case study. Psychiatry Res. 2017;258:616-617.
Jardri R, Pins D, Thomas P. A case of fMRI-guided rTMS treatment of coenesthetic hallucinations. Am J Psychiatry. 2008;165(11):1490-1491.
